BioSpace News Archive

Business

Horizon Pharma plc to Release Fourth-Quarter and Full-Year 2018 Financial Results and Host Webcast on Feb. 27, 2019

Following the announcement, Horizon’s management will host a live webcast at 8 a.m. Eastern Time to review the Company’s financial and operating results.

January 29, 2019
·
1 min read
Business

NuVasive Announces Conference Call And Webcast Of Fourth Quarter And Full Year 2018 Results

NuVasive, Inc. announced the Company will release its fourth quarter and full year 2018 earnings results on Wednesday, Feb. 20, 2019 after the close of the market.

January 29, 2019
·
2 min read
Drug Development

Shield Therapeutics plc - Positive results of long-term phase of AEGIS-CKD study further demonstrate the benefits of Feraccru®

Shield Therapeutics plc (LSE: STX) a commercial stage, pharmaceutical company with an initial focus on addressing iron deficiency, announces positive results from the open-label extension phase of the AEGIS-CKD pivotal study of Feraccru®, a novel oral ferric iron therapy that is approved and marketed in the European Union for the treatment of iron deficiency (ID) in adults and in Switzerland for the treatment of iron deficiency anaemia (IDA) in adults with inflammatory bowel disease

January 29, 2019
·
5 min read
Business

Amgen Reports Fourth Quarter And Full Year 2018 Financial Results

Amgen announced financial results for the fourth quarter and full year 2018 in comparison to comparable periods in 2017.

January 29, 2019
·
31 min read
Pharm Country

Tris Pharma, Inc. Expands Its Voluntary Nationwide Retail Recall of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, Due to Higher Concentration of Ibuprofen

Tris Pharma, Inc. is expanding the scope of its November 2018 recall by adding three (3) additional lots of Ibuprofen Oral Suspension Drops, USP, 50 mg per 1.25 mL, to the retail (pharmacy) level.

January 29, 2019
·
3 min read
Business

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2018

Illumina, Inc. announced its financial results for the fourth quarter and fiscal year 2018.

January 29, 2019
·
21 min read
Business

Mary Ellen Coe Elected to Merck Board of Directors

Merck, known as MSD outside the United States and Canada, announced that Mary Ellen Coe, president, Google Customer Solutions, at Google Inc. will join the company’s Board of Directors effective March 18, 2019.

January 29, 2019
·
4 min read
BioMidwest

Zimmer Biomet Holdings to Present at 8th Annual SVB Leerink Global Healthcare Conference

Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare, will participate in the 8th Annual SVB Leerink Global Healthcare Conference at the Lotte New York Palace in New York, New York.

January 29, 2019
·
1 min read
Biotech Bay

Cancer Researchers Highlight the Value of Droplet Digital PCR in Monitoring Immunotherapy Effectiveness at Precision Medicine World Conference

Research that demonstrates how Bio-Rad’s Droplet Digital PCR (ddPCR) technology can quickly help determine the effectiveness of immune checkpoint inhibitors and other immunotherapies will be presented by cancer researchers and medical oncologists during a Bio-Rad workshop at the Precision Medicine World Conference (PMWC) in Santa Clara, California, January 20–23.

January 29, 2019
·
5 min read
Drug Development

IMV Announces Clinical Update for DPX-Survivac Program in Ovarian Cancer Following Positive Feedback from U.S. FDA

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced updates on its clinical program for its lead investigational treatment, DPX-Survivac, as a potential monotherapy in advanced recurrent ovarian cancer

January 29, 2019
·
5 min read